» Articles » PMID: 20309922

Race, Ethnicity, Ancestry, and Pharmacogenetics

Overview
Journal Mt Sinai J Med
Specialty General Medicine
Date 2010 Mar 24
PMID 20309922
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmacogenetics is the study of how genetic variation influences the response to drugs. The concepts of race, ethnicity, and ancestry have long had a strong influence on pharmacogenetic discovery and on our understanding of population-level differences in drug response. The primary goal of pharmacogenetics, however, is to identify the individual genetic determinants of drug activity so that therapy can be tailored to the individual patient. This article describes the relationship between the concepts of race, ethnicity, and ancestry and how these concepts have been applied to pharmacogenetics, and it provides examples of the benefits and pitfalls associated with the use of racial or ethnic labels in genetic studies. The future of pharmacogenetics, including the study of rare genetic variation and what this means for racial or ethnic disparities in pharmacogenetic discovery, is also discussed.

Citing Articles

Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022.

Puhr H, Winkler E, Preusser M ESMO Open. 2025; 10(1):104093.

PMID: 39754982 PMC: 11758121. DOI: 10.1016/j.esmoop.2024.104093.


Reporting results in U.S. clinical trials for obstructive sleep apnea and insomnia: How transparent are they?.

He Z, Wallace D, Barnes A, Tang X, Jean-Louis G, Williams N Sleep Health. 2020; 6(4):529-533.

PMID: 32179065 PMC: 7486987. DOI: 10.1016/j.sleh.2019.11.009.


Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization.

Martinez S, Andresen M, Zhu Z, Papageorgiou I, Court M Sci Rep. 2020; 10(1):69.

PMID: 31919457 PMC: 6952448. DOI: 10.1038/s41598-019-56660-z.


Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.

Zhang F, Finkelstein J Pharmgenomics Pers Med. 2019; 12:107-123.

PMID: 31308725 PMC: 6612983. DOI: 10.2147/PGPM.S207449.


Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.

Williams L, Frazier A, Poynter J Int J Cancer. 2019; 146(9):2433-2441.

PMID: 31304572 PMC: 6960364. DOI: 10.1002/ijc.32569.